Literature DB >> 9065780

Structural analysis of natriuretic peptide receptor-C by truncation and site-directed mutagenesis.

M Itakura1, H Suzuki, S Hirose.   

Abstract

Natriuretic peptide receptor-C (NPR-C) has a unique structure consisting of pre-existing covalent homodimers, but it is not known whether each subunit has ligand-binding activity or whether the dimeric structure is necessary for binding activity. To answer this question, a number of C-terminally truncated mutants were designed, subcloned into the mammalian expression vector pcDNA3 and expressed by transient transfection in COS-1 cells. Truncation at position 461, which eliminates the residue Cys469 that is involved in disulphide-linked dimerization, produced a soluble and monomeric form of NPR-C, as determined by gel filtration on Superose 12. Binding assays of the gel-filtration fractions clearly demonstrated that even monomeric NPR-C contains a high-affinity binding site for natriuretic peptides. Site-directed mutagenesis of the invariant residues (Asp407-Arg408 and Asp411-Phe412) in a region highly conserved among various species established that these invariant residues are essential for ligand-binding activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065780      PMCID: PMC1218229          DOI: 10.1042/bj3220585

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Dominant negative mutations of the guanylyl cyclase-A receptor. Extracellular domain deletion and catalytic domain point mutations.

Authors:  D K Thompson; D L Garbers
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

Review 2.  The family of guanylyl cyclase receptors and their ligands.

Authors:  J G Drewett; D L Garbers
Journal:  Endocr Rev       Date:  1994-04       Impact factor: 19.871

3.  Cloning and expression of eel natriuretic-peptide receptor B and comparison with its mammalian counterparts.

Authors:  T Katafuchi; A Takashima; M Kashiwagi; H Hagiwara; Y Takei; S Hirose
Journal:  Eur J Biochem       Date:  1994-06-15

4.  A variant form of the type C atrial natriuretic peptide receptor generated by alternative RNA splicing.

Authors:  T Mizuno; M Iwashina; M Itakura; H Hagiwara; S Hirose
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

5.  His145-Trp146 residues and the disulfide-linked loops in atrial natriuretic peptide receptor are critical for the ligand-binding activity.

Authors:  M Iwashina; T Mizuno; S Hirose; T Ito; H Hagiwara
Journal:  J Biochem       Date:  1994-03       Impact factor: 3.387

6.  Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation.

Authors:  M Zhou; S Felder; M Rubinstein; D R Hurwitz; A Ullrich; I Lax; J Schlessinger
Journal:  Biochemistry       Date:  1993-08-17       Impact factor: 3.162

7.  The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.

Authors:  P M Brown; M T Debanne; S Grothe; D Bergsma; M Caron; C Kay; M D O'Connor-McCourt
Journal:  Eur J Biochem       Date:  1994-10-01

8.  A single residue determines the distinct pharmacology of rat and human natriuretic peptide receptor-C.

Authors:  A M Engel; J R Schoenfeld; D G Lowe
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

9.  Cysteine-524 is not the only residue involved in the formation of disulphide-bonded dimers of the insulin receptor.

Authors:  S L Macaulay; M Polites; D R Hewish; C W Ward
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

10.  Mutational analysis of disulfide bridges in the type C atrial natriuretic peptide receptor.

Authors:  M Itakura; M Iwashina; T Mizuno; T Ito; H Hagiwara; S Hirose
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

View more
  1 in total

1.  Comparative binding study of rat natriuretic peptide receptor-A.

Authors:  M Marquis; R Fenrick; L Pedro; M Bouvier; A De Léan
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.